20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T11424 | Glutaminyl Cyclase Inhibitor 1 | Guanylate cyclase | |
Glutaminyl Cyclase Inhibitor 1 is a glutaminyl cyclase inhibitor (IC50: 0.5 μM) that can be used to study neurological disorders. | |||
T38770 | Guanylate cyclase-IN-1 | ||
Guanylate cyclase-IN-1 (Example 46) is a specific inhibitor of guanylate cyclase, employed in research related to cardiovascular diseases. | |||
T16333 | NKY80 | Adenylyl cyclase type V Inhibitor | Adenylyl cyclase |
NKY80 regulates the adenylyl cyclase catalytic activity in heart and lung tissues. NKY80 is a non-competitive inhibitor of adenylyl cyclase type V isoform (IC50s: 8.3 µM, 132 µM, and 1.7 mM for type V, III and II, respe... | |||
T11423 | Glutaminyl Cyclase Inhibitor 4 | Others | |
Glutaminyl Cyclase Inhibitor 4 is a potent, selective glutaminyl cyclase (QC) inhibitor (IC50: 6.1 nM). It is a potent anti-Alzheimer’s agent. | |||
T11425 | Glutaminyl Cyclase Inhibitor 2 | Others | |
Glutaminyl Cyclase Inhibitor 2 is a glutaminyl cyclase inhibitor (IC50: 1.23 μM). | |||
T11422 | Glutaminyl Cyclase Inhibitor 3 | Others | |
Glutaminyl Cyclase Inhibitor 3, a designed anti-Alzheimer’s compound, is a potent human Glutaminyl Cyclase (GC) inhibitor (IC50: 4.5 nM). It significantly reduced the brain concentrations of pyroform Aβ and total Aβ and ... | |||
T72136 | Glutaminyl Cyclase Inhibitor 5 | ||
Glutaminyl Cyclase Inhibitor 5 is a potent, selective inhibitor of human glutaminyl cyclase (hQC), demonstrating an inhibition concentration half-max (IC 50) of 3.2 nM. | |||
T83169 | Adenylyl cyclase-IN-1 | ||
Adenylyl cyclase-IN-1 is a potential adenylyl cyclase inhibitor for ocular hypotonia research [1]. | |||
T63893 | Adenylyl cyclase type 2 agonist-1 | ||
Adenylyl cyclase type 2 agonist-1 is a potent agonist of adenylyl cyclase type 2 (AC2) (EC50: 90 nM). It is a potential lead compound in the fight against respiratory diseases. | |||
T15658 | KH7 | cAMP , AChR | |
KH7 is a soluble inhibitor of adenylyl cyclase (sAC)-specific. It has IC50s of 3-10 μM toward both recombinant purified human sACt protein and heterologously expressed sACt in cellular assays. KH7 is also a cAMP inhibito... | |||
T9080 | Plecanatide | Guanylate cyclase | |
Plecanatide acetate is an analogue of Uroguanylin. It is an orally active guanylate cyclase-C (GC-C) receptor agonist. | |||
T10066 | 2',5'-Dideoxyadenosine | Adenylyl cyclase , Adrenergic Receptor , AChR | |
2',5'-Dideoxyadenosine is a potent and non-competitive adenylyl cyclase inhibitor via binding the P-site (IC50: 3 μM). | |||
T16938 | ST034307 | Adenylyl cyclase | |
ST034307 is an effective and selective inhibitor of adenylyl cyclase 1 (IC50: 2.3 μM). | |||
T16808 | Runcaciguat | Others , Guanylate cyclase | |
Runcaciguat is a soluble guanylate cyclase stimulator. Runcaciguat combines with selective partial adenosine A1 receptor agonists and can be used in studies about cardiovascular and renal diseases. | |||
T11852 | Linaclotide | Guanylate cyclase | |
Linaclotide developed for the treatment of constipation-predominant irritable bowel syndrome (IBS-C) and chronic constipation, and is a potent and selective guanylate cyclase C agonist. | |||
T60003 | AC1-IN-1 | Adenylyl cyclase | |
AC1-IN-1 is a selective inhibitor of adenylyl cyclase type 1 (AC1, IC50 = 0.54 µM). | |||
T0322 | Fipexide | Dopamine Receptor , AChR | |
Fipexide (Attentil, Vigilor), a psychoactive drug of the piperazine chemical class, was developed in Italy in 1983. It was served as a nootropic drug in France and Italy, mainly for the therapy of senile dementia, but is... | |||
T21607 | Ataciguat | HMR-1766 | Others , Guanylate cyclase |
Ataciguat (HMR-1766) (HMR-1766) is a potent and specific soluble guanylate cyclase (sGC) activator. | |||
T80069 | PACAP (6-27) (human, ovine, rat) | Pituitary adenylate cyclase-activating peptide (6-27) | |
PACAP (6-27) (human, ovine, rat) serves as an antagonist for the PACAP receptor, inhibiting the catecholamine response of the canine adrenal gland to vasoactive intestinal peptide (VIP). This compound holds promise for r... | |||
T16275 | NB001 | HTS 09836 | Adenylyl cyclase |
NB001 (HTS 09836) is an inhibitor of adenyl cyclase 1 exhibiting effects on neural and non-neural pain. |